Study of long-term safety and efficacy of domestic Firebird rapamycin-eluting stent
10.3760/cma.j.issn.0254-9026.2010.11.014
- VernacularTitle:国产Firebird支架的远期安全性和有效性研究
- Author:
Xianhua YE
;
Ningfu WANG
;
Shizun GUO
;
Liang ZHOU
;
Jian XU
;
Guoxin TONG
;
Jianmin YANG
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Stent;
Safety,equipment;
Treatment effectiveness;
Follow-up studies
- From:Chinese Journal of Geriatrics
2010;29(11):920-923
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the long-term safety and efficacy of domestic Firebird rapamycin-eluting stent in treatment of patients with coronary artery disease (CAD). Methods The 465 patients with CAD received percutaneous interventional therapy with domestic Firebird or imported Cypher rapamycin-eluting stent based on patients' will and they were followed up for more than 24 months. Results The 321 cases in Firebird group were followed up for (45.3 ±11.1)months, with 166 cases (51.7%) received reexamination by coronary angiography. The 144 patients in Cypher group were followed up for (46.1 ± 12. 1) months, with 82 patients (56.3%) received reexamination by coronary angiography. At the termination of follow-up, there were no significant differences in all-cause death (7.8% vs. 7.6 %, x2 = 1.32, P = 0. 250), cardiac death (5.9% vs.5.6%, x2 =0. 02, P=0. 877), acute myocardial infarction (2.8% vs. 3.4%, x2 =0. 15, P=0. 697),cardiovascular-cause rehospitalization (29.6% vs. 31.9 %, x2 =0.26, P=0. 610), acute and subacute thrombosis events (0.9% vs. 1.3%, x2 =0.19, P=0.661), late thrombotic events (1.2% vs.1.3%, x2 =0. 02, P=0. 900) and target lesion revascularization (3.4% vs. 4.2%, x2 =0. 15, P=0. 694) between two groups. Conclusions Domestic Firebird rapamycin-eluting stent has the same or similar long-term safety and efficacy with imported Cypher rapamycin-eluting stent.
